Invention Grant
- Patent Title: Orally administered nanoparticles for gene delivery and pharmaceutical composition containing same
-
Application No.: US16096753Application Date: 2017-04-26
-
Publication No.: US11266747B2Publication Date: 2022-03-08
- Inventor: Yong-Kyu Lee , Dong Yun Lee , Sung Hun Kang , Revuri Vishnu
- Applicant: KB Biomed Inc.
- Applicant Address: KR Chungcheongbuk-do
- Assignee: KB Biomed Inc.
- Current Assignee: KB Biomed Inc.
- Current Assignee Address: KR Chungcheongbuk-do
- Agency: DLA Piper LLP US
- Priority: KR10-2016-0050955 20160426
- International Application: PCT/KR2017/004456 WO 20170426
- International Announcement: WO2017/188731 WO 20171102
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61P3/10 ; A61K47/12 ; A61K47/50 ; A61K9/00 ; A61K47/28
Abstract:
The present invention relates to a nanoparticle for oral gene delivery, which is a novel oral gene delivery system capable of regulating blood glucose levels in biological systems and insulin secretion in response to ingested meals. More specifically, the present invention relates to a nanoparticle for gene delivery, comprising: an ionic polymer conjugated with bile acid or a bile acid derivative; and a gene; and to a pharmaceutical composition comprising the same.
Public/Granted literature
- US20190111156A1 Orally Administered Nanoparticles for Gene Delivery and Pharmaceutical Composition Containing Same Public/Granted day:2019-04-18
Information query
